These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37387913)

  • 1. Retracted: Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9853753. PubMed ID: 37387913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas.
    Zhang M; Gao L; Liu X; Dong F; Su Q; Zhang Y; Li F; Wang H; Han P
    Evid Based Complement Alternat Med; 2022; 2022():3181133. PubMed ID: 36106030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical study of apatinib plus temozolomide for the treatment of recurrent high-grade gliomas.
    Yao H; Liu J; Zhang C; Shao Y; Li X; Feng M; Wang X; Gan W; Zhou Y; Huang Y
    J Clin Neurosci; 2021 Aug; 90():82-88. PubMed ID: 34275586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of apatinib combined with temozolomide in the treatment of recurrent high‑grade glioma: A meta‑analysis.
    Li G; Xu X; Cui J; Zhang F; Wang S
    Exp Ther Med; 2023 Sep; 26(3):452. PubMed ID: 37614429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: Effects of Gemcitabine and Oxaliplatin Combined with Apatinib on Immune Function and Levels of SIL-2R and sicAM-1 in Patients with Gallbladder Cancer.
    Intelligence And Neuroscience C
    Comput Intell Neurosci; 2023; 2023():9859267. PubMed ID: 37800020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: Efficacy, Safety, and Tumor Marker Inhibition of Apatinib Combined with Conventional Chemotherapy Regimens for Patients with Advanced Triple-Negative Breast Cancer.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9879023. PubMed ID: 37388035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Effects of Apatinib Mesylate Monotherapy on the Incidence of Adverse Reactions and Immune Function in Patients with Breast Cancer after Radical Mastectomy.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9861238. PubMed ID: 38093879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: Camrelizumab and Apatinib Combined with Radiotherapy Is Effective in Advanced Oligometastatic Non-Small-Cell Lung Cancer.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9826952. PubMed ID: 37387848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data.
    International BR
    Biomed Res Int; 2024; 2024():9848746. PubMed ID: 38550141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: Apatinib plus Radiotherapy on the Expression of CEA and VEGF in Advanced Oligometastatic Non-Small-Cell Lung Cancer.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9821932. PubMed ID: 38093893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Efficacy of Apatinib plus S-1 Therapy in the Treatment of Advanced Gastric Cancer Patients and the Effect on the Levels of Tumor Markers and Th1 and Th2-Like Cytokines.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9787205. PubMed ID: 38125103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: Effect of Apatinib Combined with Seggio on the Expression of Serum AFP and CA724 and Long-Term Survival Rate in Patients with Advanced Gastric Cancer Undergoing Comfortable Nursing Intervention.
    Healthcare Engineering JO
    J Healthc Eng; 2022; 2022():9756408. PubMed ID: 36530787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: Apatinib Promotes Apoptosis of Pancreatic Cancer Cells through Downregulation of Hypoxia-Inducible Factor-1
    Longevity OMAC
    Oxid Med Cell Longev; 2024; 2024():9786072. PubMed ID: 38234535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment with apatinib for refractory recurrent malignant gliomas: a case series.
    Zhang H; Chen F; Wang Z; Wu S
    Onco Targets Ther; 2017; 10():837-845. PubMed ID: 28243119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apatinib in recurrent anaplastic meningioma: a retrospective case series and systematic literature review.
    Wang Y; Li W; Jing N; Meng X; Zhou S; Zhu Y; Xu J; Tao R
    Cancer Biol Ther; 2020 Jul; 21(7):583-589. PubMed ID: 32212907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Correlations between Clinical Characteristics and Prognosis in Patients with Grade II Glioma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9765049. PubMed ID: 37387973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: Knockdown of lncRNA
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9859158. PubMed ID: 37501828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Apatinib for the Treatment of Advanced or Recurrent Cervical Cancer: A Single-Arm Meta-Analysis Among Chinese Patients.
    Huang D; He Q; Zhai L; Shen J; Jing F; Chen H; Zhu X; Zhou J
    Front Pharmacol; 2022; 13():843905. PubMed ID: 36034824
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness and prognostic factors of apatinib treatment in patients with recurrent or advanced cervical carcinoma: A retrospective study.
    Yang H; Chen M; Mei Z; Xie C; Zhou Y; Qiu H
    Cancer Med; 2021 Jul; 10(13):4282-4290. PubMed ID: 33987959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: Identification and Potential Mechanisms of a 7-MicroRNA Signature That Predicts Prognosis in Patients with Lower-Grade Glioma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9807106. PubMed ID: 38094830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.